tradingkey.logo
tradingkey.logo

KORU Medical Systems Inc

KRMD
6.230USD
-0.250-3.86%
終値 12/26, 16:00ET15分遅れの株価
288.41M時価総額
損失額直近12ヶ月PER

KORU Medical Systems Inc

6.230
-0.250-3.86%

詳細情報 KORU Medical Systems Inc 企業名

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Incの企業情報

企業コードKRMD
会社名KORU Medical Systems Inc
上場日Oct 27, 1993
最高経営責任者「CEO」Tharby (Linda M)
従業員数80
証券種類Ordinary Share
決算期末Oct 27
本社所在地100 Corporate Drive
都市MAHWAH
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号07430
電話番号18454692042
ウェブサイトhttps://www.korumedical.com/
企業コードKRMD
上場日Oct 27, 1993
最高経営責任者「CEO」Tharby (Linda M)

KORU Medical Systems Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+1.41%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
91.52K
+4.47%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
88.89K
+4.61%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
88.53K
+4.63%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
41.69K
+10.37%
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+1.41%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
91.52K
+4.47%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
88.89K
+4.61%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
88.53K
+4.63%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Domestic Core
7.10M
69.62%
International Core
2.18M
21.38%
Novel Therapies
917.40K
9.00%
地域別USD
会社名
収益
比率
Domestic
8.01M
78.59%
International
2.18M
21.41%
事業別
地域別
事業別USD
会社名
収益
比率
Domestic Core
7.10M
69.62%
International Core
2.18M
21.38%
Novel Therapies
917.40K
9.00%

株主

更新時刻: Thu, Nov 20
更新時刻: Thu, Nov 20
株主統計
種類
株主統計
株主統計
比率
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.63%
Tharby (Linda M)
4.58%
他の
60.47%
株主統計
株主統計
比率
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.63%
Tharby (Linda M)
4.58%
他の
60.47%
種類
株主統計
比率
Hedge Fund
22.21%
Investment Advisor/Hedge Fund
17.73%
Investment Advisor
15.79%
Individual Investor
8.38%
Pension Fund
0.84%
Research Firm
0.33%
Bank and Trust
0.10%
Insurance Company
0.03%
他の
34.58%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Horton Capital Management LLC
5.87M
12.7%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.68M
10.13%
-32.76K
-0.69%
Jun 30, 2025
Topline Capital Management, LLC
3.61M
7.8%
-212.88K
-5.57%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.51%
+321.66K
+18.23%
Jun 30, 2025
Tharby (Linda M)
2.09M
4.52%
+293.63K
+16.34%
Apr 21, 2025
BlackRock Institutional Trust Company, N.A.
1.67M
3.6%
+1.49M
+818.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
997.15K
2.16%
+501.88K
+101.33%
Jun 30, 2025
Meros Investment Management, LP
850.39K
1.84%
+103.83K
+13.91%
Jun 30, 2025
Acuitas Investments LLC
402.49K
0.87%
+337.28K
+517.17%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
詳細を見る
iShares Micro-Cap ETF
比率0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.03%
iShares Russell 2000 ETF
比率0.01%
Global X Russell 2000 ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
ProShares Hedge Replication ETF
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%
ProShares UltraPro Russell2000
比率0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0%
DFA Dimensional US Sustainability Core 1 ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

KORU Medical Systems Incの上位5名の株主は誰ですか?

KORU Medical Systems Incの上位5名の株主は以下のとおりです。
Horton Capital Management LLCは5.87M株を保有しており、これは全体の12.70%に相当します。
First Light Asset Management, LLCは4.68M株を保有しており、これは全体の10.13%に相当します。
Topline Capital Management, LLCは3.61M株を保有しており、これは全体の7.80%に相当します。
The Vanguard Group, Inc.は2.09M株を保有しており、これは全体の4.51%に相当します。
Tharby (Linda M)は2.09M株を保有しており、これは全体の4.52%に相当します。

KORU Medical Systems Incの株主タイプ上位3種は何ですか?

KORU Medical Systems Incの株主タイプ上位3種は、
Horton Capital Management LLC
First Light Asset Management, LLC
Topline Capital Management, LLC

KORU Medical Systems Inc(KRMD)の株式を保有している機関の数はいくつですか?

2025Q3時点で、KORU Medical Systems Incの株式を保有している機関は175社あり、保有株式の総市場価値は約25.43Mで、全体の54.99%を占めています。2025Q2と比較して、機関の持ち株は-6.39%増加しています。

KORU Medical Systems Incの最大の収益源は何ですか?

FY2025Q2において、Domestic Core部門がKORU Medical Systems Incにとって最大の収益を生み出しており、その金額は7.10Mで、全収益の69.62%を占めています。
KeyAI